Experimental evidence for the topical use of angiotensin-converting enzyme inhibitors in eye drops for eye ischemia treatment

Purpose: to evaluate the topical use effect of angiotensin-converting enzyme (ACE) inhibitor (iACE) Enalaprilat in eye drops on eye blood flow volume, hypoxia degree, ACE activity, and total antioxidant activity (TAA) in aqueous humor of rabbits with experimental ocular ischemia.Material and methods...

Full description

Saved in:
Bibliographic Details
Main Authors: N. B. Chesnokova, O. A. Kost, O. V. Beznos, A. V. Grigoryev, P. V. Binevski, T. A. Pavlenko
Format: Article
Language:Russian
Published: Real Time Ltd 2022-09-01
Series:Российский офтальмологический журнал
Subjects:
Online Access:https://roj.igb.ru/jour/article/view/1059
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849696626471337984
author N. B. Chesnokova
O. A. Kost
O. V. Beznos
A. V. Grigoryev
P. V. Binevski
T. A. Pavlenko
author_facet N. B. Chesnokova
O. A. Kost
O. V. Beznos
A. V. Grigoryev
P. V. Binevski
T. A. Pavlenko
author_sort N. B. Chesnokova
collection DOAJ
description Purpose: to evaluate the topical use effect of angiotensin-converting enzyme (ACE) inhibitor (iACE) Enalaprilat in eye drops on eye blood flow volume, hypoxia degree, ACE activity, and total antioxidant activity (TAA) in aqueous humor of rabbits with experimental ocular ischemia.Material and methods. Transient ocular ischemia in 30 Chinchilla rabbits was induced by subconjunctivally injecting 0.2 ml of 1 % Phenylephrine. Ocular ischemia degree was assessed by the minute volume of blood flow (MBF), determined with the help of ophthalmic plethysmography. 0.125 % Enalaprilat was administered by instillations. A CE activity in aqueous humor was measured using a spectrofluorometric assay with 0.1 mM Z-Phe-His-Leu substrate; the degree of hypoxia was estimated by the level of lactate in aqueous humor, which was determined by the enzymatic amperometric method. TAA was determined by registering chemiluminescence kinetics in the hemoglobin-H2O2-luminol model system.Results. A single instillation of iACE in the intact rabbit eye caused a decline of MBF value and A CE activity in aqueous humor. In ocular ischemia, ACE activity and t he lactate level in aqueous humor are increasing, while TAA is decreasing. Enalaprilat instillation in the eyes with ischemia lead to the normalization of MBF, ACE activity, lactate level and TAA in aqueous humor.Conclusion. Topical iACE in eye drops can penetrate eye tissues. Instillations of iACE during ischemia cause a remarkable increase of eye blood flow and reduce ACE activity, which is increased in ischemia. The anti-ischemic effect of iACE is accompanied by antihypoxant and antioxidant effects. Thus, iACE in eye drops can be used in ophthalmology as an anti-ischemic agent.
format Article
id doaj-art-ffd295a2e879452383bd712c00e1fd07
institution DOAJ
issn 2072-0076
2587-5760
language Russian
publishDate 2022-09-01
publisher Real Time Ltd
record_format Article
series Российский офтальмологический журнал
spelling doaj-art-ffd295a2e879452383bd712c00e1fd072025-08-20T03:19:24ZrusReal Time LtdРоссийский офтальмологический журнал2072-00762587-57602022-09-0115311812210.21516/2072-0076-2022-15-3-118-122506Experimental evidence for the topical use of angiotensin-converting enzyme inhibitors in eye drops for eye ischemia treatmentN. B. Chesnokova0O. A. Kost1O. V. Beznos2A. V. Grigoryev3P. V. Binevski4T. A. Pavlenko5Helmholtz National Medical Research Center of Eye DiseasesMoscow State UniversityHelmholtz National Medical Research Center of Eye DiseasesHelmholtz National Medical Research Center of Eye DiseasesMoscow State UniversityHelmholtz National Medical Research Center of Eye DiseasesPurpose: to evaluate the topical use effect of angiotensin-converting enzyme (ACE) inhibitor (iACE) Enalaprilat in eye drops on eye blood flow volume, hypoxia degree, ACE activity, and total antioxidant activity (TAA) in aqueous humor of rabbits with experimental ocular ischemia.Material and methods. Transient ocular ischemia in 30 Chinchilla rabbits was induced by subconjunctivally injecting 0.2 ml of 1 % Phenylephrine. Ocular ischemia degree was assessed by the minute volume of blood flow (MBF), determined with the help of ophthalmic plethysmography. 0.125 % Enalaprilat was administered by instillations. A CE activity in aqueous humor was measured using a spectrofluorometric assay with 0.1 mM Z-Phe-His-Leu substrate; the degree of hypoxia was estimated by the level of lactate in aqueous humor, which was determined by the enzymatic amperometric method. TAA was determined by registering chemiluminescence kinetics in the hemoglobin-H2O2-luminol model system.Results. A single instillation of iACE in the intact rabbit eye caused a decline of MBF value and A CE activity in aqueous humor. In ocular ischemia, ACE activity and t he lactate level in aqueous humor are increasing, while TAA is decreasing. Enalaprilat instillation in the eyes with ischemia lead to the normalization of MBF, ACE activity, lactate level and TAA in aqueous humor.Conclusion. Topical iACE in eye drops can penetrate eye tissues. Instillations of iACE during ischemia cause a remarkable increase of eye blood flow and reduce ACE activity, which is increased in ischemia. The anti-ischemic effect of iACE is accompanied by antihypoxant and antioxidant effects. Thus, iACE in eye drops can be used in ophthalmology as an anti-ischemic agent.https://roj.igb.ru/jour/article/view/1059angiotensin-converting enzymeangiotensin-converting enzyme inhibitorshypoxiaocular ischemiaaqueous humorantioxidant activitylactateophthalmic plethysmography
spellingShingle N. B. Chesnokova
O. A. Kost
O. V. Beznos
A. V. Grigoryev
P. V. Binevski
T. A. Pavlenko
Experimental evidence for the topical use of angiotensin-converting enzyme inhibitors in eye drops for eye ischemia treatment
Российский офтальмологический журнал
angiotensin-converting enzyme
angiotensin-converting enzyme inhibitors
hypoxia
ocular ischemia
aqueous humor
antioxidant activity
lactate
ophthalmic plethysmography
title Experimental evidence for the topical use of angiotensin-converting enzyme inhibitors in eye drops for eye ischemia treatment
title_full Experimental evidence for the topical use of angiotensin-converting enzyme inhibitors in eye drops for eye ischemia treatment
title_fullStr Experimental evidence for the topical use of angiotensin-converting enzyme inhibitors in eye drops for eye ischemia treatment
title_full_unstemmed Experimental evidence for the topical use of angiotensin-converting enzyme inhibitors in eye drops for eye ischemia treatment
title_short Experimental evidence for the topical use of angiotensin-converting enzyme inhibitors in eye drops for eye ischemia treatment
title_sort experimental evidence for the topical use of angiotensin converting enzyme inhibitors in eye drops for eye ischemia treatment
topic angiotensin-converting enzyme
angiotensin-converting enzyme inhibitors
hypoxia
ocular ischemia
aqueous humor
antioxidant activity
lactate
ophthalmic plethysmography
url https://roj.igb.ru/jour/article/view/1059
work_keys_str_mv AT nbchesnokova experimentalevidenceforthetopicaluseofangiotensinconvertingenzymeinhibitorsineyedropsforeyeischemiatreatment
AT oakost experimentalevidenceforthetopicaluseofangiotensinconvertingenzymeinhibitorsineyedropsforeyeischemiatreatment
AT ovbeznos experimentalevidenceforthetopicaluseofangiotensinconvertingenzymeinhibitorsineyedropsforeyeischemiatreatment
AT avgrigoryev experimentalevidenceforthetopicaluseofangiotensinconvertingenzymeinhibitorsineyedropsforeyeischemiatreatment
AT pvbinevski experimentalevidenceforthetopicaluseofangiotensinconvertingenzymeinhibitorsineyedropsforeyeischemiatreatment
AT tapavlenko experimentalevidenceforthetopicaluseofangiotensinconvertingenzymeinhibitorsineyedropsforeyeischemiatreatment